ID

22722

Descrizione

Study part: Adverse Events Run-In Visits. A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.

Keywords

  1. 11/06/17 11/06/17 -
Titolare del copyright

GlaxoSmithKline

Caricato su

11 giugno 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :


Non ci sono commenti

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Adverse Events Run-In Visits Mepolizumab HES NCT00086658

Adverse Events Run-In Visits

ADVERSE EVENTS
Descrizione

ADVERSE EVENTS

Alias
UMLS CUI-1
C0877248 (Adverse event)
LOINC
MTHU014542
AE's and SAE's related to study participation during the screening and Prednisone stabilization period reported?
Descrizione

Adverse Events

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0877248 (Adverse event)
LOINC
MTHU014542

Similar models

Adverse Events Run-In Visits

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
ADVERSE EVENTS
C0877248 (UMLS CUI-1)
Adverse Events
Item
AE's and SAE's related to study participation during the screening and Prednisone stabilization period reported?
boolean
C0877248 (UMLS CUI [1])

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial